Acetaminophen and its regioisomer, 3-acetamidophenol interfered with the growth ofEscherichia coli O157:H7
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Escherichia coli O157:H7 (O157) is an enterohemorrhagic pathogenic subtype, causing diarrhea and Hemolytic-uremic syndrome (HUS). Treatment for HUS patients might be accompanied with antibiotics and antispasmodics with analgesics for abdominal pain. Antiperistaltic effect of antispasmodics, however, may increase the risk of infection of O157 through the intestine. If analgesics also have antibacteiral effect, the prevention and cure of O157 could get benefits. Akhter, T.et al. (2010) reported the inhibitory effect of ibuprofen (IBF) on the bacterial isolates from infected urinary tract. Here, we also found that acetaminophen (4-AAP) and its regioisomer, 3-acetamidophenol (3-AAP), constrained the growth of O157. Inhibitory effect was compared with IBF, since they were both COX inhibitors for their inhibitory mechanism. The experiment results showed that O157 growth was reduced in the presence of 4-AAP, 3-AAP, and IBF. Among them, the inhibitory effect of 4-AAP was less than 3-AAP and IBF in 1.8 fold at 10 mM concentrations. In addition, 4-AAP and 3-AAP inhibited the activity of endogenous peroxidase ofE. coli, as well as, horseradish peroxidase (HRP), implying its possible inhibitory mechanism. However, IBF did not inhibit peroxidase activity, suggesting the different mechanism to suppress the growth of O157 by 4-AAP and 3-AAP.
- Karmali, M. A. Infection by verocytotoxin-producingEscherichia coli. Clin. Microbiol. Rev. 2, 15–38 (1989).
- Karmali, M. A. Infection by Shiga toxin-producingEscherichia coli: an overview.Mol. Biotechnol. 26, 117–122 (2004). CrossRef
- Besser, R. E.et al. An outbreak of diarrhea and hemolytic uremic syndrome fromEscherichia coli O157: H7 in fresh-pressed apple cider.JAMA. 269, 2217–2220 (1993). CrossRef
- Ackers, M. L.et al. An outbreak ofEscherichia coli O157:H7 infections associated with leaf lettuce consumption.J. Infect. Dis. 177, 1588–1593 (1998). CrossRef
- Wong, C. S.et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment ofEscherichia coli O157:H7 infections.N. Engl. J. Med. 342, 1930–1936 (2000). CrossRef
- Tarr, P. I., Gordon, C. A. & Chandler, W. L. Shigatoxin-producingEscherichia coli and haemolytic uremic syndrome.Lancet. 365, 1073–1086 (2005).
- Tarr, P. I. & Neill, M. A.Escherichia coli O157:H7.Gastroenterol. Clin. North. Am. 30, 735–751 (2001). CrossRef
- Hinz, B., Cheremina, O. & Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man.FASEB. J. 22, 383–390 (2008). CrossRef
- García-Rodríguez, L. A. & Hernández-Díaz, S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs.Epidemiology.12, 570–576 (2001). CrossRef
- Mielke, C. H. Jr. Comparative effects of aspirin and acetaminophen on hemostasis.Arch. Intern. Med. 141, 305–310 (1981). CrossRef
- Catella-Lawson, F.et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.N. Engl. J. Med. 345, 1809–1817 (2001). CrossRef
- James, L. P., Mayeux, P. R. & Hinson, J. A. Acetaminophen-induced hepatotoxicity.Drug. Metab. Dispos. 31, 1499–1506 (2003). CrossRef
- Salminen, W. F. Jr., Voellmy, R. & Roberts, S. M. Differential heat shock protein induction by acetaminophen and a nonhepatotoxic regioisomer, 3′-hydroxyacetanilide, in mouse liver.J. Pharmacol. Exp. Ther. 282, 1533–1540 (1997).
- Matthews, A. M., Hinson, J. A., Roberts, D. W. & Pumford, N. R. Comparison of covalent binding of acetaminophen and the regioisomer 3′-hydroxyacetanilide to mouse liver protein.Toxicol. Lett. 90, 77–82 (1997). CrossRef
- An, S. S., Kim, M. G. & Chung, B. H. Detection ofEscherichia coli O157:H7 using its endogenous active membrane peroxidase.Submitted (2010).
- Akhter, T., Baqai, R. & Aziz, M. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection.Pak. J. Pharm. Sci. 23, 108–113 (2010).
- Prescott, L. F., Roscoe, P., Wright, N. & Brown, S. S. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage.Lancet.1, 519–522 (1971). CrossRef
- O’Malley, P. Too much of a good thing: paracetamol (acetaminophen) toxicity: update for the clinical nurse specialist.Clin. Nurse. Spec. 19, 18–19 (2005). CrossRef
- Pappas, A. A., Taylor, E. H. & Ackerman, B. Toxicology and Drugs of Abuse, in: Howanitz, J., Howanitz, P. (Eds), Laboratory Medicine: Test Selection and Interpretation, New York, 382 (1991).
- Nelson, E. B. Method for analgesia using 3-hydroxyacetanilide. US Patent 4238508. 9 Dec (1980).
- Sakamoto, M. & Komagata, K. Aerobic growth of and activities of NADH oxidase and NADH peroxidase in lactic acid bacteria.J. Ferment. Bioeng. 82, 210–216 (1996). CrossRef
- Condon, S. Responses of lactic acid bacteria to oxygen.FEMS Microbiol. Rev. 46, 269–280 (1987). CrossRef
- Sakamoto, M., Uchimura, T. & Komagata, K. Comparison of H2O-forming NADH oxidase from Leuconostoc mesenteroides subsp. mesenteroides NRIC 1541T and H2O2-forming NADH oxidase from Sporolactobacillus inulinus NRIC 1133T.J. Ferment. Bioeng. 82, 531–537 (1996). CrossRef
- Sakamoto, M., Tano, Y., Uchimura, T. & Komagata, K. Aerobic growth of some lactic acid bacteria enabled by the external addition of peroxidase (Horseradish) to the culture medium.J. Ferment. Bioeng. 85, 627–629 (1998). CrossRef
- Acetaminophen and its regioisomer, 3-acetamidophenol interfered with the growth ofEscherichia coli O157:H7
Toxicology and Environmental Health Sciences
Volume 2, Issue 4 , pp 278-283
- Cover Date
- Print ISSN
- Springer Netherlands
- Additional Links
- E. coli O157:H7
- Growth rate